Cite

HARVARD Citation

    Xu, B. et al. (2021). Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial. Lancet. 398 (10317), pp. 2149-2159. [Online]. 
  
Back to record